Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Beverly, Wuertz"'
Autor:
Alexandra Lesnick, Tina L. Samuels, Donna Seabloom, Beverly Wuertz, Abhilash Ojha, Davis Seelig, Frank Ondrey, Timothy S. Wiedmann, Chris Hogan, Emma Torii, Hui Ouyang, Ke Yan, Guilherme J. M. Garcia, Jonathan M. Bock, Nikki Johnston
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 9, Iss 1, Pp n/a-n/a (2024)
Abstract Objectives Approximately 25% of Americans suffer from laryngopharyngeal reflux (LPR), a disease for which no effective medical therapy exists. Pepsin is a predominant source of damage during LPR and a key therapeutic target. Fosamprenavir (F
Externí odkaz:
https://doaj.org/article/10ed8a7c18e849f5abc41f2314e40880
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Objective Determine the interchangeability of various methods utilized for counting colonies in clonogenic assays. Methods Clonogenic assays of 2 head and neck cancer cell lines were counted through 4 different counting modalities: Manual counting pe
Externí odkaz:
https://doaj.org/article/e8cc99ce4fd74456a508dd1078800fb9
Autor:
Andrew C. Elton, Vannesa Cedarstrom, Arman Quraishi, Beverly Wuertz, Kevin Murray, Todd W. Markowski, Donna Seabloom, Frank G. Ondrey
Publikováno v:
Nutrition and Cancer. 75:1014-1027
Autor:
Nikki Johnston, Tina L. Samuels, Christopher J. Goetz, Leggy A. Arnold, Brian C. Smith, Donna Seabloom, Beverly Wuertz, Frank Ondrey, Timothy S. Wiedmann, Nemanja Vuksanovic, Nicholas R. Silvaggi, Alexander C. MacKinnon, James Miller, Jonathan Bock, Joel H. Blumin
Publikováno v:
The Laryngoscope. 133
More than 20% of the US population suffers from laryngopharyngeal reflux. Although dietary/lifestyle modifications and alginates provide benefit to some, there is no gold standard medical therapy. Increasing evidence suggests that pepsin is partly, i
Autor:
Mark Christian Rusten, Frank G. Ondrey, Raed D. Abughazaleh, Beverly Wuertz, Paul J. Escher, Vannesa Souksavong, Jeffrey A. Hall
Publikováno v:
Head Neck
BACKGROUND: Peroxisome proliferator-activated receptor-gamma (PPAR-γ) activators have anti-cancer effects. Our objective was to determine the effect of PPAR-γ ligands 15-deoxy-D(12,14)-Prostaglandin J(2) (15-PGJ(2)) and ciglitazone on proliferation
Publikováno v:
Cancer Research. 82:5950-5950
Introduction: Fanconi Anemia (FA) patients develop head and neck squamous cell carcinoma (HNSCC) at significantly elevated rates and conventional adjunctive chemotherapy and radiation are exquisitely toxic to these patients. We endeavor to find a saf
Autor:
Charles S. Coffey, Julie E. Bauman, Valerie D. Butler, J. Silvio Gutkind, H-H. Sherry Chow, Denise M. Laronde, Chiu Hsieh Hsu, Stephen M. Hewitt, Beverly Wuertz, Ezra E.W. Cohen, Lisa Bengtson, Zhiyong Wang, Olivier Harismendy, Alfredo A. Molinolo, Frank G. Ondrey, Ludmil B. Alexandrov, Xingyu Wu, Daniela Nachmanson, Scott M. Lippman, Leigha D. Rock, Miriam P. Rosin, Eva Szabo
Publikováno v:
JCI Insight
JCI insight, vol 6, iss 17
JCI insight, vol 6, iss 17
BACKGROUND The aberrant activation of the PI3K/mTOR signaling circuitry is one of the most frequently dysregulated signaling events in head and neck squamous cell carcinoma (HNSCC). Here, we conducted a single-arm, open-label phase IIa clinical trial
Publikováno v:
International forum of allergyrhinologyReferences. 11(5)
Publikováno v:
Anticancer research. 40(6)
BACKGROUND/AIM Head and neck squamous cell carcinoma affects nearly 500,000 people annually. Augmenting PPARγ functional activation is linked with multiple anti-carcinogenic processes in aerodigestive cell lines and animal models. PPARγ/RXRα heter
Publikováno v:
Cancer Research. 81:2568-2568
Successful Fanconi anemia (FA) treatment allows greater longevity for these patients. However, there is a greatly increased risk of squamous malignancies of the head and neck which are quite deadly in these young patients. There is an unmet need for